Metastatic nonsquamous non-small cell lung cancer

Clinical trials for Metastatic nonsquamous non-small cell lung cancer explained in plain language.

Never miss a new study

Get alerted when new Metastatic nonsquamous non-small cell lung cancer trials appear

Sign up with your email to follow new studies for Metastatic nonsquamous non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Immunotherapy combo shows promise in advanced lung cancer trial

Disease control Completed

This phase 3 study tested whether adding the immunotherapy drug retifanlimab (INCMGA00012) to standard platinum-based chemotherapy helps people with advanced non-small cell lung cancer live longer. The trial enrolled 583 patients who had not received prior treatment for metastati…

Matched conditions: METASTATIC NONSQUAMOUS NON-SMALL CELL LUNG CANCER

Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Metastatic nonsquamous non-small cell lung cancer

Get alerted when new Metastatic nonsquamous non-small cell lung cancer trials appear

Immunotherapy combo shows promise in advanced lung cancer trial